These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9389080)

  • 1. [Inhibition of the development of Plasmodium yoelii in exoerythrocytic stage in rodents (rats) with Chrysanthemum morifolium].
    Zhao C; Ruan H; Lei Y; Wu Y; Voelter W; Jung A; Schick M
    J Tongji Med Univ; 1996; 16(4):200-2. PubMed ID: 9389080
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of the antimalarial drugs ferroquine and artesunate on Plasmodium yoelii yoelii gametocytegenesis and vectorial transmission.
    Mustfa K; Landau I; Chabaud AG; Chavatte JM; Chandenier J; Duong TH; Richard-Lenoble D
    Sante; 2011; 21(3):133-42. PubMed ID: 22294247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of Nosema algerae on the development of Plasmodium yoelii nigeriensis in Anopheles stephensi.
    Schenker W; Maier WA; Seitz HM
    Parasitol Res; 1992; 78(1):56-9. PubMed ID: 1584748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium yoelii yoelii 17XNL constitutively expressing GFP throughout the life cycle.
    Ono T; Tadakuma T; Rodriguez A
    Exp Parasitol; 2007 Mar; 115(3):310-3. PubMed ID: 17049517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of some factors on the development of exoerythrocytic stage of Plasmodium yoelii].
    Luo SH; Liu D; Shu HP; Fu RD
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1993; 11(2):98-101. PubMed ID: 8174223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [System model of Plasmodium yoelii--Anopheles stephensi for screening tissue schizontocides].
    Huang WZ; Zhang JX; Ye XY; Pan YR; Luo MZ; Lin BY; Wang LC; Ni QH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Aug; 4(4):229-33. PubMed ID: 6217911
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential activity of methylene blue against erythrocytic and hepatic stages of Plasmodium.
    Bosson-Vanga H; Franetich JF; Soulard V; Sossau D; Tefit M; Kane B; Vaillant JC; Borrmann S; Müller O; Dereuddre-Bosquet N; Le Grand R; Silvie O; Mazier D
    Malar J; 2018 Apr; 17(1):143. PubMed ID: 29615050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the development of the hepatic stages of Plasmodium yoelii nigeriensis by antihistaminic agents.
    Singh N; Puri SK
    Ann Trop Med Parasitol; 1999 Jun; 93(4):419-22. PubMed ID: 10656045
    [No Abstract]   [Full Text] [Related]  

  • 9. Synchronized Plasmodium yoelii yoelii: pattern of gametocyte production, sequestration and infectivity.
    Gautret P; Miltgen F; Chabaud AG; Landau I
    Parassitologia; 1996 Dec; 38(3):575-7. PubMed ID: 9257348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemotherapy of rodent malaria XLI. Causal prophylaxis. Part V. Effect of mefloquine on exoerythrocytic schizogony in Plasmodium yoelii yoelii.
    Boulard Y; Landau I; Miltgen F; Peters W; Ellis DS
    Ann Trop Med Parasitol; 1986 Dec; 80(6):577-80. PubMed ID: 3499879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium yoelii nigeriensis: biological mechanisms of resistance to chloroquine.
    Beauté-Lafitte A; Altemayer-Caillard V; Chabaud AG; Landau I
    Parasite; 1994 Sep; 1(3):227-33. PubMed ID: 9140489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of species A, B, and C of Anopheles culicifacies complex to Plasmodium yoelii yoelii and Plasmodium vinckei petteri infections.
    Kaur S; Singh OP; Adak T
    J Parasitol; 2000 Dec; 86(6):1345-8. PubMed ID: 11191914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Toll-Like Receptor 2 agonist PEG-Pam
    Ernest M; Hunja C; Arakura Y; Haraga Y; Abkallo HM; Zeng W; Jackson DC; Chua B; Culleton R
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):451-458. PubMed ID: 30396012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
    Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
    PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of alcohol extracts of Chrysanthemum morifolium on Plasmodium falciparum in vitro].
    Zhao C; Wu Y; Lei Y; Ruan H; Voelter W; Jung A; Schick M
    J Tongji Med Univ; 1996; 16(4):203-4. PubMed ID: 9389081
    [No Abstract]   [Full Text] [Related]  

  • 16. [A preliminary study on the inhibitory action of target-primaqine on the exoerythrocytic forms of Plasmodium yoelii yoelii].
    Song J; Wang X; Huang F; Feng C; Zhang Z; Huo Y; Pang Q
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):117-9. PubMed ID: 7554159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rodent systems (Plasmodium berghei-Anopheles Stephensi) for screening compounds for potential causal prophylaxis.
    Most H; Montuori WA
    Am J Trop Med Hyg; 1975 Mar; 24(2):179-82. PubMed ID: 1091166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cultivation of exo-erythrocytic schizonts of rodent Plasmodium in hepatocytes: a new experimental model for chemotherapy of malaria].
    Millet P; Landau I; Baccam D; Miltgen F; Peters W
    C R Acad Sci III; 1985; 301(8):403-6. PubMed ID: 3933782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium yoelii: oral delivery of 5-fluoroorotate to treat malaria in mice.
    Rathod PK; Gomez ZM
    Exp Parasitol; 1991 Nov; 73(4):512-4. PubMed ID: 1959576
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study on the exoerythrocytic forms of Plasmodium yoelii yoelii in rats and mice].
    Zhang JX; Lin BY; Pan YR
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1990; 8(4):288-90. PubMed ID: 2099260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.